Medicine guide
BLISTEX DCT
As listed in the register: BLISTEX DCT
7.3 % + 4.5 % + 0.6 % + 0.48 % + 0.38 % · ointment
- Available without prescription
- Skin
- Active substance
- Octinoxate + Oxybenzone + Menthol + Phenol + Camphor
- Used in
- Skin
- Made by
- Blistex Corporation
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupSkinD02BA30
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Blistex Corporation |
|---|---|
| Active substance | Octinoxate + Oxybenzone + Menthol + Phenol + Camphor |
| Used in | Skin |
| Strength | 7.3 % + 4.5 % + 0.6 % + 0.48 % + 0.38 % |
| Form | ointment |
| Classification | D02BA30 · Skin |
| Route | topical |
| Dispensing (as stated by the register) | NON-PRESCRIPTION DRUGS |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02157292 |
| DPD drug code | 42607 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.